Clinical Trials Directory

Trials / Completed

CompletedNCT02502032

Effects of Cisatracurium on Sccinylcholine-induced Fasciculations

Effects of Pretreatment With Different Doses of Cisatracurium on Succinylcholine-induced Fasciculations

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
87 (actual)
Sponsor
Zhuan Zhang · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

To investigate the effects of different doses of cisatracurium pretreatment on succinylcholine-induced fasciculations.

Detailed description

Ninety patients scheduled for laparoscopic cholecystectomies were equally randomized into three groups to receive pretreatment of 0.005, 0.01, and 0.02 mg/kg cisatracurium, respectively. General anesthesia was induced 3.5 min later, train of four stimulation was monitored 4.5 min later, succinylcholine 1.5 mg/kg was injected 5 min later, and endotracheal intubation was implemented 6.5 min later. The side effects of cisatracurium, intensity of fasciculations, intubating conditions, time and extent to maximal depression of twitch and time for its recovery to 20% of control value, severity of myalgia at 24 h postoperatively, serum potassium before cisatracurium pretreatments, at intubating time, and 5 min after intubation were recorded.

Conditions

Interventions

TypeNameDescription
DRUGCisatracuriumDifferent groups received different pretreatments of cisatracurium.

Timeline

Start date
2015-07-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2015-07-17
Last updated
2015-10-12

Source: ClinicalTrials.gov record NCT02502032. Inclusion in this directory is not an endorsement.